Jeffery A. Smisek, Director at Finch Therapeutics Group, Inc. (FNCH), sold 8,242 shares at $2.57 ($21K) on 2024-03-28, disclosed to the SEC on 2024-03-29.
Open-market sale of $21k FNCH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.57 | 6,642 | $17K | 80.3% |
| 2 | $2.61 | 1,600 | $4K | 19.7% |
| Total | $2.58 avg | 8,242 | $21K | 100% |
| Filing → |
| UAL | BUY | 2014-04-28 | $792K | — | Filing → |
| UAL | BUY | 2013-08-27 | $250K | — | Filing → |
| NOV | SELL | 2013-03-15 | $115K | — | Filing → |